The largest genetic study to date into long-term health conditions of later life has identified opportunities for new ways to treat multiple overlapping conditions.   

Currently, nine million people in the UK live with two or more long-term conditions at the same time (multimorbidity). Their treatment accounts for half of the NHS budget.  

Led by the University of Exeter Medical School and funded by the Medical Research Council and the National Institute for Health Research, the GEMINI study looked at both genetics and clinical information from more than three million people in the UK and Spain.   

Published in eBioMedicine, the research has identified genetic overlaps in 72 long-term health conditions associated with ageing, to identify where specific genes are linked to two or more conditions.  

With more than 2,500 combinations of conditions analysed, the programme aims to unlock cases where a drug or prevention strategies can prevent or delay the onset of multimorbidity.  

It also revealed genetic connections that explain why certain conditions may be more likely to co-occur in the same patient.  

Dr Joao Delgado, University of Exeter Medical School, led the research. He said: “We’re now working to drill down into specific combinations of conditions, and expect to reveal drugs or lifestyle changes that already work for treating existing conditions that can be repurposed to prevent multimorbidity, with promising results. For example, we identified the role of treatable conditions, such as B12 deficiency and iron deficiency anaemia in the development of multimorbidity. This will lead to a more personalised approach to prevention and treatment in multimorbidity.”  

The paper is entitled ‘A systematic analysis of the contribution of genetics to multimorbidity and comparisons with primary care data’. The research was supported by the NIHR Exeter Biomedical Research Centre.

Diana Spencer, Senior Digital Content Editor, DDW